Best GLP-1 Microdosing Providers (2026): Doctor-Reviewed, Ranked

Pricing in full: Compounded semaglutide/tirzepatide from $99/mo (entry/microdose; realistic ~$199–$399/mo, cheapest tiers need 3–12-month prepay) · brand path (Wegovy/Ozempic/Zepbound/Mounjaro) adds ~$39/mo membership · oral Rybelsus available · HSA/FSA eligible

Found (joinfound.com, Found Health Inc.) has run physician-designed weight care since 2019 and reports 250k+ members. An intake is reviewed by obesity-medicine clinicians, then care is paired with a behavioral-coaching program — app, 1:1 coaching, and community — plus insurance navigation. The formulary is unusually broad: compounded semaglutide and tirzepatide, brand-name Wegovy/Ozempic/Zepbound/Mounjaro, oral Rybelsus, and even non-GLP oral options, prescribed in all 50 states. In October 2025 Found launched a dedicated GLP-1 microdosing program, which is directly relevant to a start-low approach. Pricing is layered rather than flat: a compounded entry advertised 'as low as $99/mo' (the microdose/entry tier), with realistic ongoing cost around $199–$399/mo, and the cheapest rates requiring a 3–12-month prepay; the brand pathway stacks a ~$39/mo membership on top.

Pricing in full: $149/mo microdose tirzepatide and $179/mo standard compounded, both on a yearly subscription · $199/mo on a 3-month plan · brand Ozempic from $1,299/mo · no month-to-month rate published

An online intake is reviewed by Gala's clinical team (AI Coaching, Inc., with care delivered through OpenLoop-affiliated medical groups), then compounded semaglutide or tirzepatide is shipped to you. The prices are public rather than quiz-gated, which is worth something on this board — but every one of them is a yearly commitment: the $179/mo headline sits directly above the words "All doses included. Yearly subscription", the $149/mo microdose tier carries the same term, and the shortest plan quoted anywhere is $199/mo over three months. Gala is LegitScript-verified, markets itself as a women's brand ("dosed for women's bodies"), states all 50 states without publishing a list, and runs a full HRT/menopause line beside the metabolic one. A brand-name pathway (Ozempic from $1,299/mo) sits alongside the compounded arm.

Pricing in full: Compounded semaglutide $212/mo (first month $112) · tirzepatide $280/mo · tirzepatide microdose $169/mo · sema+tirz combo $322/mo · optional NAD+

Enhance MD is a compounded-only GLP-1 telehealth practice that publishes its full price ladder up front: semaglutide at $212/mo (a discounted $112 first month), standard tirzepatide at $280/mo, a low-dose tirzepatide microdose at $169/mo, and a semaglutide+tirzepatide combination at $322/mo, with an optional NAD+ add-on. Dosing is flat within each tier, an online intake is reviewed by a provider, and the program builds in metabolic lab testing roughly every six months as part of ongoing care.

Pricing in full: Real, FDA-approved brand-name GLP-1 through a cash-pay marketplace — e.g., the Wegovy oral pill from $149/mo — plus a separate Sesame platform subscription (two-part cost). Carries Wegovy (injectable pen + oral pill), Zepbound, Ozempic, Mounjaro, and oral Rybelsus.

Sesame Care (sesamecare.com) is an established national telehealth marketplace, operating since 2018, that connects patients with independent cash-pay clinicians. It is LegitScript-certified and BBB-listed, and it carries the widest real brand-name GLP-1 lineup on this list: brand Wegovy in both the injectable pen and the oral pill, plus Zepbound, Ozempic, Mounjaro, and oral Rybelsus. The microdose-relevant angle is start-low access to FDA-approved brand-name products — including oral options such as the Wegovy pill from $149/mo — rather than a dedicated microdosing protocol. Cost is two-part: the medication price plus a separate Sesame platform subscription. As a generalist marketplace, it is not a specialized low-dose clinic.

Pricing in full: Compounded semaglutide from $194/mo on the 12-month plan ($199 for 6 months, $219 for 3 months, $249 month-to-month) · compounded tirzepatide $329/mo · semaglutide oral capsules $249/mo — each price includes the consult, medication, supplies, shipping, and support.

RxSpan MD (rxspanmd.com) is a physician-led telehealth practice founded by Dr. John Diaz, a board-certified plastic surgeon. It runs an unusually broad menu: compounded semaglutide and tirzepatide in both injectable and oral-capsule form, an advertised brand-name GLP-1 lane, and a microdosing lane — the last two directly relevant to a start-low approach — alongside longevity (NAD+/sermorelin/glutathione), hair-loss, and sexual-health lines. Pricing is published transparently on its own product pages and is all-inclusive: compounded semaglutide runs from $194/mo on the 12-month plan (up to $249 month-to-month), compounded tirzepatide is $329/mo, and semaglutide oral capsules are $249/mo, with the consult, medication, supplies, shipping, and support all folded into that single price. Plans can be changed or cancelled anytime, and RxSpan prescribes in all 50 states.

Pricing in full: Compounded GLP injectable ~$189/mo · oral GLP tablet ~$239/mo · GLP+GIP ~$349/mo (company-stated)

HealthRX is a LegitScript-certified (#50087439) physician-supervised telehealth practice for medical weight loss. A licensed-provider intake gates access, then compounded semaglutide or tirzepatide is dispensed from US pharmacies at transparent monthly pricing with no insurance required. It is one of the few programs to carry a rare oral GLP tablet alongside injectables. Company-stated pricing runs roughly $189/mo for the compounded GLP injectable, ~$239/mo for the oral tablet, and ~$349/mo for a GLP+GIP tier. The microdose-relevant angle is transparent, low-dose-friendly monthly pricing rather than membership-stacked billing.

Pricing in full: Microdosing protocol $179/mo · compounded semaglutide $199/mo · compounded tirzepatide $299/mo · optional NAD+ $249/mo · optional yourEra Optimum membership +$149/mo (coaching, nutritionist, at-home labs)

yourEra (yourera.com) is a compounded GLP-1 and longevity telehealth practice that publishes its pricing openly: a dedicated microdosing protocol at $179/mo — the low-dose lane most directly relevant to a start-low approach — alongside compounded semaglutide at $199/mo and compounded tirzepatide (dual GIP/GLP-1) at $299/mo, plus an optional NAD+ line at $249/mo. An online intake is reviewed by a licensed clinician, then a weekly injectable is shipped; there is no brand-name or oral pathway. yourEra markets a 50-state licensed-clinician network, takes no insurance, and accepts HSA/FSA. An optional yourEra Optimum membership (+$149/mo) layers on 1:1 coaching, a nutritionist, at-home lab draws, and wearables.

Pricing in full: Microdosed tirzepatide as low as $116/mo (list $279 — the rate depends on plan length) · oral tirzepatide from $129/mo · semaglutide from $99/mo · flat as your dose is titrated

A LegitScript-certified telehealth that publishes four GLP-1 routes side by side and lets a licensed provider match you to one after a five-minute intake. For a low-dose reader the important one is Microdosed Tirzepatide — a genuine separate product at a lower dose and a lower price than the full-dose injection, rather than a full-dose plan you underuse. A needle-free oral tirzepatide sits beside it. The catch is plan length: every figure is an "as low as" that assumes the longest commitment, and the microdose page shows $279 struck through above its $116. Month-to-month you pay near the top of that range, and the site does not publish the intermediate tiers.

Pricing in full: Flat monthly pricing for low-dose compounded semaglutide or tirzepatide, with no separate membership or lab fee (confirm the current rate on Trimi's site before starting).

An online intake is reviewed by a licensed provider, then a low-dose compounded semaglutide or tirzepatide protocol is shipped to you. Trimi is built specifically around microdosing — small, appetite- and metabolic-baseline-oriented amounts rather than aggressive titration — and folds the medication into a single flat monthly price with no separate membership stacked on top. It is a leaner offering than CoreAge: strong on price structure, lighter on named-pharmacy transparency and included human support.

Pricing in full: Compounded semaglutide $149/mo · compounded tirzepatide $199/mo · plus a real brand-name Wegovy/Zepbound pathway. Injectable only.

Sprout Health (joinsprouthealth.com) is a LegitScript-certified telehealth practice offering compounded semaglutide at $149/mo and compounded tirzepatide at $199/mo, alongside a real brand-name Wegovy/Zepbound pathway. It is built for low friction — no labs and often no synchronous visit — with an intake quiz gating which states it serves. On this microdose-focused site the honest caveat matters: Sprout dispenses standard-dose compounded GLP-1, not a dedicated microdosing protocol, so a start-low approach means self-directing a lower dose within a standard plan. The compounded medication is 503A and not FDA-approved, and there is no named medical director.

Pricing in full: Compounded semaglutide $119/mo · tirzepatide $169/mo · oral semaglutide drops $199 / troche $249 · oral tirzepatide drops $249 (advertised floors)

Try Ageless (tryageless.com) is a compounded telehealth storefront with an unusually broad menu: compounded semaglutide at $119/mo and tirzepatide at $169/mo in both injectable and oral (sublingual drops / troche) formats, alongside NAD+, sermorelin, low-dose naltrexone, methylene blue, and TRT. It is 100% online — a licensed clinician reviews an online intake, then medication ships discreetly, with no insurance and Klarna/Affirm financing. The low headline pricing and oral GLP-1 formats are the microdose-relevant angle: starting low on an inexpensive, needle-optional plan. Everything is compounded (not FDA-approved) through 503A/503B partner pharmacies, and the advertised prices are floors — the final price is set after clinical review. Try Ageless does not publish a state-availability list, shipping only 'to eligible U.S. locations.'

Pricing in full: Compounded semaglutide $179 first month, then $159/mo (3-mo) → $139/mo (12-mo) · compounded tirzepatide $209 first month → $139/mo (12-mo) · also NAD+, sermorelin, ED, and a deep peptide catalog

Bodybuilding Health+ (bbhealthplus.com) is the compounded-telehealth arm of the long-running retailer Bodybuilding.com, operated under license by Dynamo Group LLC and launched around April 2026. An online intake is reviewed by an independent licensed provider, then compounded semaglutide or tirzepatide is filled by a U.S.-registered compounding pharmacy — free until a provider approves you. Pricing is published openly and drops sharply with commitment: semaglutide from $179 the first month down to $139/mo on the 12-month bundle, tirzepatide from $209 down to $139/mo, so it's easy to start on a low, entry-tier dose. The same login also carries NAD+, sermorelin, ED (tadalafil), and an unusually deep peptide catalog — a natural fit for the lifter and longevity crowd. The draw is a recognizable fitness-brand name plus genuinely low bundle pricing; the caution is that it's brand-new, compounded, and sells on a strict final-sale basis.

Pricing in full: Compounded semaglutide ~$179/mo sublingual, ~$297/mo injectable · tirzepatide ~$224/mo sublingual, ~$399/mo injectable · promo pricing ~$147 (company-stated)

Direct Meds launched in 2024 as a compounded-only GLP-1 program and stands out for offering oral/sublingual drops alongside standard injectables — a format most competitors do not carry. Pricing is all-inclusive with no separate membership: roughly $179/mo for sublingual semaglutide and $297/mo injectable, with tirzepatide around $224/$399, plus promotional pricing near $147. Both molecules are available. The figures come from the company's own press release rather than a live, verifiable checkout, and the brand appears across multiple domains, so confirm the current offer directly before starting.

Pricing in full: GLP-1 liquid drops from $229/mo · lozenges from $199/mo · compounded semaglutide injection $199/mo · tirzepatide injection $299/mo (both fall on 6- and 12-month plans)

A weight-loss platform rather than a single-format prescriber, and the format range is the point for a low-dose reader: GLP-1 liquid drops and lozenges sit alongside the standard weekly injection, and a drop or lozenge is a far more forgiving vehicle for taking less than a full dose than trying to draw a partial unit from a vial. Brand Zepbound and Wegovy are available for anyone who wants to switch tracks, health coaching is included with membership, and GLP-1s are prescribed in all 50 states.

Pricing in full: Compounded semaglutide from $99/mo sublingual or $149/mo injectable · tirzepatide from $199/mo either route (auto-refill rates)

Asynchronous telehealth: a U.S.-licensed physician reviews an online intake, typically within a business day, and in many states no phone consultation is required. For a low-dose reader the draw is format and price together — the same molecules are sold as sublingual lozenges at the same price as the injection, and semaglutide sublingual is the cheapest entry on this board at $99/mo on auto-refill. Free physician visit, free shipping and free follow-up care are included rather than billed separately.

Pricing in full: Tirzepatide $299 first month then $399/mo · $1,068 for three months · $1,918 for six · semaglutide from $199/mo — every figure quoted at the lowest dosage

A LegitScript-certified nationwide programme whose pricing only appears inside the intake. What makes it relevant here is the pricing basis: the funnel states plainly that its figures are based on the lowest dosage rates and that higher doses may cost more. On a general board that is a warning; for someone deliberately staying at a low dose it is the only model here that charges accordingly rather than billing a full-dose flat rate. Nothing is charged until a provider approves you, and the consult is free if you proceed.

Pricing in full: Advertised from $199/mo across weight-loss treatments (one shared figure, not per molecule) · brand Ozempic from $705/mo · per-dose pricing quiz-gated

A LegitScript-certified, HIPAA-compliant multi-service platform bundling weight loss with hair, TRT, sexual health and NAD+. For a low-dose reader the relevant part is route: it carries oral tirzepatide as well as injectable, plus oral Rybelsus and a brand Ozempic pathway — an unusually wide set of ways to take a small amount. The cost is transparency: one "from $199/mo" covers every weight-loss treatment, and per-dose prices only appear once you are through the intake quiz.

Pricing in full: Semaglutide $239/mo quarterly (from $199 on six months) · tirzepatide $399/mo quarterly (from $369 on six) — the SAME price at every dose

LegitScript-verified compounded telehealth that publishes its price at every single dose — semaglutide 0.25mg through 2.4mg, tirzepatide 2.5mg through 15mg, one figure throughout. Oral semaglutide and oral tirzepatide are offered alongside the injections, which is what earns it a place here. But the flat structure cuts both ways for this audience: it removes any surprise as you titrate up, and it means someone deliberately staying at a quarter dose pays the same as someone at the full one.

Pricing in full: Pricing not published

A telehealth weight-management platform with an unusually wide catalogue for this board — compounded semaglutide and tirzepatide each available as a weekly injection OR an oral dissolving tablet, four branded pens, and sermorelin. For a low-dose reader the ODT route is the draw: a tablet is a far more forgiving vehicle for a small dose than a syringe. What you cannot do is cost it. No price appears anywhere on the public site, the pricing page 404s, and every product link routes into a two-minute quiz. Two claims on its own homepage also fail against the rest of the site.

Pricing in full: Compounded semaglutide $99/mo · tirzepatide $199/mo (medication) + Eden Membership ($39 first month, then $99/mo)

Online intake with a licensed provider; compounded semaglutide or tirzepatide is shipped from a state-licensed or 503A pharmacy. Eden advertises the same price at every dose, which lets you titrate from a low starting dose. The advertised medication price covers medication only — an active Eden Membership is required and billed separately.

Pricing in full: Mochi Membership $39 first month, then $79/mo (medication billed separately, not membership-included)

Video visit with an obesity-medicine provider and dietitian, then compounded or branded semaglutide in injectable and oral formats. Membership is required and billed separately from medication; the medication price is shown only after an eligibility request, so a low-dose figure cannot be confirmed publicly.

Pricing in full: From $79 first 4 weeks, then $199/mo (12-week subscription) — meds, visits, and support bundled

Noom's Microdose GLP-1Rx track pairs an expert-clinician evaluation with its coaching app. Noom leans on FDA-approved branded products (Wegovy/Ozempic, Zepbound/Mounjaro) and may prescribe compounded versions where appropriate. The bundle folds medication, clinical visits, and coaching into one subscription price.

Pricing in full: Compounded semaglutide microdose $155/mo (4 doses, dose-flat) · standard sema $175/mo · compounded tirzepatide higher

Online medical evaluation with ongoing provider access, then compounded semaglutide (microdose and standard) or tirzepatide shipped to you. Ivy Rx positions itself specifically around microdosing and prices the microdose plan dose-flat at $155/mo for four doses, so a low starting dose costs the same as a higher one. Injectable, tablet, and sublingual formats are offered.

Pricing in full: Compounded semaglutide microdose $199/mo · compounded tirzepatide microdose $199/mo (medication billed separately)

Provider visit on Lemonaid's telehealth platform, then compounded semaglutide or tirzepatide in a microdose track, with brand referral where appropriate. The advertised $199/mo figures cover the medication; the provider visit is billed separately from the medication on this platform.

Pricing in full: Program $75 first month, then $149/mo ($75/mo annual) · compounded sema microdose $155/mo (standard $175) · brand Zepbound $349–$499 via Lilly

Board-certified physicians run the evaluation and prior-authorization/insurance navigation. LifeMD pairs Lilly/Novo brand partnerships (brand Wegovy/Zepbound) with a compounded arm that includes a low-dose semaglutide microdose option. The program fee is charged separately from the medication, so the totals stack.

Pricing in full: Microdose semaglutide and microdose tirzepatide both $149/mo month-to-month (4-week supply, cancel anytime) · $129/mo billed $387 quarterly · $119/mo billed $714 every 6 months · $109/mo billed $1,308 annually — against $279/mo month-to-month for its standard compounded tirzepatide

A 2-minute intake, a clinician review inside 24 hours, and a compounded GLP-1 shipped within 48 hours. What earns Lttl a place here is that "Microdose" is a product line with its own page and its own four-rung price ladder, not a smaller amount of a weight-loss plan: microdose semaglutide and microdose tirzepatide are both priced identically and both land far below the standard weight-loss line. The whole matrix is published before checkout, which is rarer on this board than it should be. The catch is which rung the marketing quotes — the $109/mo shown on the category card is the 52-week prepay rate, and the price you can actually leave after a month is $149.

Pricing in full: Semaglutide Microdose: 2-month program $246.00, billed and shipped every 2 months (the site states this as $123/month) · its Low-Dose program is quoted as low as $246/month shipping monthly · semaglutide program from $247 · tirzepatide program from $296

A longevity-framed telehealth practice that does something almost no one else here does: it treats "Microdose" and "Low-Dose" as two distinct programs with different purposes and different prices, and says so on the product page. The microdose is sold as a two-month program billed and shipped every other month, with shipping, supplies, consultation and unlimited clinical support included in the figure. That is genuinely the cheapest low-dose structure verified on this board — but the headline number is an amortisation, not a bill you receive, and there is no monthly-billed microdose option at all.

Pricing in full: Semaglutide Microdose Program from $197.00 (shown as a sale price against a $591.00 regular price) · Tirzepatide Microdose Program from $297.00 — the term each "from" figure covers is not stated on the card

A direct-to-consumer storefront whose GLP-1 menu is organised the way a microdoser would organise it: "Microdose GLP" is its own navigation category, and both molecules appear inside it as named Microdose Programs with public prices. That is a real advantage over the quiz-gated operators on this board. What sits beside it is the problem. The same storefront sells ivermectin and an ivermectin-plus-mebendazole combination as retail products, and the pricing cards carry a "from" figure against a much larger "regular price" without saying what period either covers.

Pricing in full: New-patient intro $89 for the first month, then $199/month thereafter, cancel anytime — one care-inclusive price covering the protocol, consultations, shipping and monitoring

A single-product practice: physician-titrated microdose tirzepatide, with a board-certified MD or DO reviewing the intake inside 24 hours and issuing a written plan and titration schedule. There is no full-dose ladder to be upsold onto, which removes the usual pressure a microdoser feels on a general platform, and the price is one care-inclusive figure rather than a medication rate with consults and shipping billed underneath. The reservation is not the price. It is that the site argues its case with a comparison table of expected results at a 1 mg microdose, sourced to observational and dose-ranging data rather than to any trial of the protocol it sells.

Pricing in full: Microdosing compounded semaglutide flat $199 at any strength (30-day supply) · microdosing compounded tirzepatide flat $229 at any strength (30-day supply) · against a standard ladder whose first rung is $189 for semaglutide and $199 for tirzepatide at 2.5 mg/wk, rising to $299 and $389 at the top doses

One of the very few operators on this board that publishes a genuine per-dose price ladder: six tirzepatide tiers from 2.5 mg/wk up to 15 mg/wk, each with its own 30-day figure, plus 90-day programs, all before intake. A licensed U.S. provider is seen by video inside 24 hours and the money is fully refunded — not credited — if you are not approved. It also sells a named microdose line, flat at any strength, bundled with B12 and glycine. And that is where the arithmetic turns against the reader this site is written for: the microdose costs more per month than simply starting on the bottom rung of the standard ladder.

Pricing in full: Compounded semaglutide with glycine and B12 from $196/mo, billed quarterly with a three-month commitment paid up front · "Microdose" is a selectable dosage type at that same from-price · no membership fee

Bryan Johnson's longevity telehealth arm, selling compounded semaglutide bundled with glycine and B12 and framing GLP-1s as a longevity intervention rather than a weight-loss one — which is the frame most microdosers actually arrive in. Physicians are licensed in your state, follow-up messaging is unlimited for up to twelve months, there is no membership fee, and intake-to-door runs three to seven days. For a low-dose reader the structural problem is plain: "Microdose" is offered as a dosage type inside the same product at the same from-price, so choosing to take less does not reduce what you pay, and there is no monthly option to leave from.